CA Patent

CA2683657A1 — Multipurpose diseased tissue detection devices, systems and methods

Assigned to Apteryx Imaging Inc · Expires 2007-10-18 · 19y expired

What this patent protects

An autofluorescence light examination system having a plurality of modular parts includes a main body, a light source, and at least two detachable instruments. The main body is configured to deliver light to a target tissue and contains at least one optical element configured so …

USPTO Abstract

An autofluorescence light examination system having a plurality of modular parts includes a main body, a light source, and at least two detachable instruments. The main body is configured to deliver light to a target tissue and contains at least one optical element configured so that a user can directly view the target tissue through the main body while the target tissue is illuminated by the light source. The main body is further configured to accept at least two detachable instruments that are configured to deliver light to at least two different target tissues located at at least two different areas of the body and configured such that a user can directly view the target tissue through the main body while the target tissue is illuminated by the light source.

Drugs covered by this patent

Patent Metadata

Patent number
CA2683657A1
Jurisdiction
CA
Classification
Expires
2007-10-18
Drug substance claim
No
Drug product claim
No
Assignee
Apteryx Imaging Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.